Swiss National Bank Oramed Pharmaceuticals Inc. Transaction History

Swiss National Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$3.72 - $9.0 $318,060 - $769,500	-85,500 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$8.19 - $13.89 $172,809 - $293,079	21,100 Added 32.76%	85,500 $740,000
Q4 2021 Feb 08, 2022	BUY	$12.98 - $29.75 $835,912 - $1.92 Million	64,400 New	64,400 $920,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.9M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.